Skip to content

ECmedic: what changed

BE 1013.346.330Other company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
€51,939
2024 · -€4,937+€56,876
Equity
€52,001
2024 · €63+€51,939
Cash
€18,471
2024 · €6,873+€11,598
Balance sheet total
€284,895
2024 · €43,745+€241,150

Largest movements

2024 to 2025
Assets
  • Tangible fixed assets +€223,316

    up €223,316 (+622%), from €35,912 to €259,228

  • Cash +€11,598

    up €11,598 (+169%), from €6,873 to €18,471

    mainly Debts after one year (+€197,857) and Net result for the year (+€51,939)

  • Deferred charges and accrued income +€6,236

    up €6,236 (+650%), from €960 to €7,196

Equity and liabilities
  • Debts after one year +€197,857

    first reported in 2025, at €197,857

  • Profit (loss) carried forward +€51,939

    up €51,939, from -€4,937 to €47,001

  • Other debts -€28,364

    down €28,364 (-76.1%), from €37,280 to €8,916

  • Current portion of long-term debt +€11,526

    first reported in 2025, at €11,526

  • Tax, wage and social debts +€11,508

    up €11,508 (+511%), from €2,250 to €13,758

Income statement
  • Gross operating margin +€120,193

    up €120,193, from -€4,102 to €116,091

  • Depreciation +€45,311

    up €45,311 (+8,811%), from €514 to €45,825

  • Taxes +€13,652

    first reported in 2025, at €13,652

  • Financial charges +€4,371

    first reported in 2025, at €4,371

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 -€4,937
Gross operating margin +€120,193
Depreciation -€45,311
Other operating charges +€19
Financial income -€1
Financial charges -€4,371
Taxes -€13,652
Result 2025 €51,939
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€71,356
Investment -€269,141
Financing +€209,384
Cash 2024 €6,873
Net result for the year +€51,939
Depreciation +€45,825
Deferred charges and accrued income -€6,236
Trade debts -€3,316
Tax, wage and social debts +€11,508
Other debts -€28,364
Investment in fixed assets (net) -€269,141
Debts after one year +€197,857
Current portion of long-term debt +€11,526
Cash 2025 €18,471
brings cash intakes cash out
Every line side by side 33 lines
Line Code 2024 2025 Change %
Total assets 20/58 €43,745 €284,895 +€241,150 +551%
Fixed assets 21/28 €35,912 €259,228 +€223,316 +622%
Tangible fixed assets 22/27 €35,912 €259,228 +€223,316 +622%
Land and buildings 22 €35,912 €259,228 +€223,316 +622%
Current assets 29/58 €7,833 €25,667 +€17,834 +228%
Cash at bank and in hand 54/58 €6,873 €18,471 +€11,598 +169%
Deferred charges and accrued income 490/1 €960 €7,196 +€6,236 +650%
Total equity and liabilities 10/49 €43,745 €284,895 +€241,150 +551%
Equity 10/15 €63 €52,001 +€51,939 +82,877%
Contributions 10/11 €5,000 €5,000 = 0.0%
Profit (loss) carried forward 14 -€4,937 €47,001 +€51,939
Amounts payable 17/49 €43,682 €232,894 +€189,211 +433%
Amounts payable after more than one year 17 - €197,857 +€197,857
Financial debts 170/4 - €197,857 +€197,857
Amounts payable within one year 42/48 €43,682 €35,036 -€8,646 -19.8%
Current portion of amounts payable after more than one year 42 - €11,526 +€11,526
Trade debts 44 €4,152 €836 -€3,316 -79.9%
Suppliers 440/4 €4,152 €836 -€3,316 -79.9%
Taxes, remuneration and social security 45 €2,250 €13,758 +€11,508 +511%
Taxes 450/3 €2,250 €13,758 +€11,508 +511%
Other amounts payable 47/48 €37,280 €8,916 -€28,364 -76.1%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €514 €45,825 +€45,311 +8,811%
Other operating charges 640/8 €322 €303 -€19 -5.8%
Gross operating margin 9900 -€4,102 €116,091 +€120,193
Operating profit (loss) 9901 -€4,938 €69,962 +€74,900
Financial income 75/76B €1 - -€1
Recurring financial income 75 €1 - -€1
Financial charges 65/66B - €4,371 +€4,371
Recurring financial charges 65 - €4,371 +€4,371
Profit (loss) for the period before taxes 9903 -€4,937 €65,590 +€70,528
Income taxes 67/77 - €13,652 +€13,652
Profit (loss) for the period 9904 -€4,937 €51,939 +€56,876
Profit (loss) for the period to be appropriated 9905 -€4,937 €51,939 +€56,876

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€109,933 to €143,506

Midpoint €123,922 · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years earnings weight 50%

Worked out with Checked's starting values, not your estimate and not market data. Change the assumptions: the value follows.

Adjusted equity €52,001
Capitalised earnings €167,864 to €235,010
Indication €109,933 to €143,506

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
€52,001
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€52,001

Capitalised earnings

net result for the year (9904)
2025
€51,939
2024
-€4,937
Average result
€23,501
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€167,864 / €195,842 / €235,010

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The result is not corrected for the manager's pay. If the company pays less or more than a market salary, the capitalised earnings are too high or too low.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 16 November 2026 via checked.be.